🌸 PCOS in Indian Women: The Facts & The Myth
- Team Quikphyt

- Oct 7, 2025
- 6 min read
“PCOS is not your fault—but with the right plan, it can be managed powerfully.”
Why it Matters (Especially in India)
Recent Indian data suggest 7–20% of women meet diagnostic criteria for PCOS (wide range due to different criteria), with college-going women in Delhi-NCR ~17%—that’s 1 in 6. (JAMA Network)
South Asians develop insulin resistance and diabetes at lower BMI; the cardiometabolic risk arrives earlier and at leaner weights than in many other populations. (PMC)
For Asian Indians, overweight begins at BMI ≥23 and obesity at ≥25, so “normal BMI” by Western charts may still be risky for us. (PMC)
What PCOS is (and is Not)
Diagnostic Criteria (Adults)
PCOS is a clinical syndrome diagnosed when any 2 of 3 are present after excluding mimics:
Ovulatory dysfunction (infrequent/absent periods)
Clinical/biochemical hyperandrogenism (hirsutism, acne; elevated androgens)
Polycystic ovarian morphology (PCOM) or elevated AMH (per 2023 update)(Exclude thyroid disease, hyperprolactinemia, non-classic CAH, Cushing’s, and androgen-secreting tumors.) (PMC)
Important 2023 Updates
Adolescents: Do NOT use ultrasound/AMH for diagnosis; require both persistent cycle irregularity (relative to years since menarche) and hyperandrogenism. Many teens show “PCOM-like” ovaries normally; label as “at risk” and follow up. (MDPI)
Ultrasound thresholds (adults): modern transvaginal US suggests ≥20 follicles/ovary or ovarian volume ≥10 mL as PCOM. (Older 12-follicle cut offs over diagnose.) (MDPI)
How Common is PCOS in India?
Meta-analysis (India):Â Pooled prevalence ~11.3%Â with Rotterdam criteria. (PMC)
National/Regional snapshots:Â 7.2% (NIH criteria)Â vs ~19.6% (Rotterdam)Â across multiple Indian cohorts; Delhi-NCR student cohort 17.4%Â (2024). (JAMA Network)
Why we’re at higher risk: South Asian women with PCOS tend to have higher insulin levels and lower insulin sensitivity compared with Caucasian women—raising long-term risks of type 2 diabetes and CVD. (PMC)
Comprehensive PCOS Screening (The QuikPhyt Baseline)
At Diagnosis (Adults & Teens):
Glucose: Prefer 75-g OGTT (fasting + 2-hour), as it detects problems missed by fasting glucose/HbA1c; recheck every 1–3 years based on risk. (OUP Academic)
Lipids, BP, BMI & Waist:Â at baseline; use Asian Indian BMI cut-offs. (Monash University)
Mental health: Screen for depression/anxiety using validated tools (PHQ-9/GAD-7). (Monash University)
Sleep & Liver: Screen for sleep apnea risk (snoring, daytime sleepiness) and check ALT; PCOS carries higher metabolic and sleep disorder burden. (Monash University)
Gynaecologic: If >90 days without periods, induce withdrawal bleed (to protect the endometrium) and evaluate per guidelines. (PMC)
Lifestyle is First-Line (and Powerful)
Exercise (Minimum Effective Dose, then Build)
Aim for 150–300 min/week moderate or 75–150 min/week vigorous aerobic activity plus 2–3 days/week strength training; this improves insulin resistance and ovulation. (ScienceDirect)
HIIT can match or outperform standard cardio for insulin sensitivity, VO₂max, menstrual cyclicity in PCOS—use if you enjoy it and can recover well. (PubMed)
Meal-time walks (10–15 min) blunt post-meal glucose spikes; add NEAT (steps, stairs, chores).
Nutrition (Indian Plate, Low GI Emphasis)
Evidence favours low-GI / high-fibre patterns for insulin sensitivity; think millets (ragi, bajra), legumes (dal/chana/rajma), whole dals/veg, nuts, seeds; minimize Maida, Sugar-Sweetened Beverages, Ultra-Processed Snacks. (PMC)
Protein with each meal (veg or non-veg) supports satiety, muscle, glucose control; vegetarians: dal + dahi/paneer + soy/tofu + nuts/seeds.
Weight change target: even 5–7% loss improves cycles/metabolic health; but benefit occurs even without weight loss when fitness and diet quality improve. (ScienceDirect)
S
tress, Sleep, Circadian Hygiene
Mind-body (yoga, meditation, breathwork) improves HRV/stress axis; 7–9 hours regular sleep improves insulin action; screen for OSA if snoring/daytime sleepiness. (Monash University)
Evidence-Based Medical Therapy (Personalized)
For Irregular Cycles, Acne, Hirsutism (not seeking Pregnancy):
COCP (combined oral contraceptive pill) is first-line to regulate cycles and lower androgens. Use lowest effective ethinyl estradiol dose; reassess periodically. (cosrh.org)
If hirsutism persists after ~6 months: add antiandrogen (e.g., spironolactone). Must use reliable contraception due to teratogenic risk. Consider laser/photoepilation ± topical eflornithine for facial hair. (OUP Academic)
For Metabolic Features (IR, Pre-Diabetes, Higher BMI):
Metformin improves insulin sensitivity, weight trajectory, and cycle regularity; particularly useful in overweight/obese or high-risk ethnic groups. Monitor B12 with long-term use. (Lifestyle remains foundational.) (eshre.eu)
Fertility (Seeking Pregnancy):
Letrozole is first-line ovulation induction in PCOS (superior to clomiphene for live birth in most studies). Escalate per protocol; consider gonadotropins/IVF if resistant. (OUP Academic)
❌ALWAYS TAKE YOUR DOCTOR'S OR PHYSICIAN'S ADVICE BEFORE ANY LIFESTYLE CHANGES AND/OR MEDICATION.❌
Supplements: what’s Solid, what’s Optional
Inositols (myo-/D-chiro; often 40:1): evidence is mixed; some RCTs/meta-analyses show metabolic/reproductive benefits, others find inconclusive effects. Consider only as an adjunct, after discussing uncertainty and cost. (PubMed)
Vitamin D: deficiency is common; treat deficiency, but it’s not a primary PCOS therapy. Some RCTs show metabolic benefits when deficient. (PubMed)
Omega-3 (EPA/DHA): meta-analyses suggest improvements in triglycerides, HOMA-IR; best over ≥8 weeks. Helpful if hypertriglyceridemia or low fish intake. (PMC)
Bottom line: Lifestyle + guideline-directed meds are core. Supplements are optional adjuncts, targeted to deficiencies or specific metabolic goals.
PCOS across life stages (India-specific pearls)
Adolescents: Diagnose carefully (avoid over-labelling). Treat symptoms; focus on habits, skin, and cycle regulation. Avoid ultrasound/AMH for diagnosis in the first 8 years post-menarche. (MDPI)
Preconception: Optimize weight/fitness, correct iron, vitamin D, B12, and aim for stable cycles; discuss letrozole as first-line if anovulatory. (OUP Academic)
Pregnancy: PCOS is high-risk (GDM, hypertensive disorders). Early OGTT and close monitoring advised. (Monash University)
Long-term: Recheck glucose (OGTT) and lipids every 1–3 years; maintain strength + cardio as “non-negotiables.” (OUP Academic)

The QuikPhyt 12-Week PCOS Action Plan (implementable)
Weeks 1–2: Baseline & Reset
Labs: OGTT, lipids, ALT, TSH, prolactin, androgens; PHQ-9/GAD-7; OSA screen. Start 150 min/week cardio + 2 strength days; 10-min walk after meals.
Weeks 3–6: Build Consistency
Progress to 200–250 min/week cardio or HIIT 2x/wk if tolerated; progressive strength (lower-upper-full body split).
Plate: ½ veg, ¼ dal/beans/lean protein, ¼ whole grains/millets; 30–40 g protein/meal.
Weeks 7–12: Personalize & Measure
If irregular cycles/hirsutism: consider COCP; reassess at 3 months.
If IR/prediabetes or BMI ≥23 with central adiposity: add metformin.
If trying to conceive: plan letrozole cycle after lifestyle phase-in.
Track: waist, cycles, energy, acne/hair, strength/VO₂. Re-check fasting lipids/glucose as advised.
(Our coaches at QuikPhyt Health Hub & Gym can deliver a hyper-individualised plan matching time, goals, and medical profile.)
Myth vs Fact (Shareable)
“PCOS = always Obese.” ❌ Many Indian women with PCOS are not obese yet still insulin-resistant. ✔️ (PMC)
“Ultrasound is mandatory to diagnose.” ❌ Not if you already have irregular cycles + hyperandrogenism (adults). ✔️ (Monash University)
“Teen acne + irregular periods = PCOS.” ❌ Adolescents need both, persistent irregular cycles and hyperandrogenism; no US/AMH early after menarche. ✔️ (MDPI)
“HIIT is dangerous for PCOS.” ❌ Appropriately progressed HIIT can improve insulin sensitivity and cycles. ✔️ (PubMed)
Key References (High-Quality)
International PCOS Guideline (2023 update) – assessment, screening, and management recommendations. (OUP Academic)
Monash/ESHRE/ASRM PDF summaries – detailed criteria, lifestyle chapter, OGTT preference. (Monash University)
India-specific prevalence – JAMA Network Open (2024); Indian meta-analysis (2022); Delhi-NCR cohort (2024). (JAMA Network)
South Asian metabolic risk – comparative studies on insulin resistance. (PMC)
Exercise & PCOS – 2024 review and RCTs (HIIT vs moderate). (ScienceDirect)
Low-GI nutrition – systematic review/meta-analysis. (PMC)
Hirsutism management – Endocrine Society guidance & 2023 meta-analysis (antiandrogens). (OUP Academic)
Supplements evidence – Inositol (inconclusive 2024), omega-3 meta-analyses, vitamin D in deficiency. (PubMed)
Asian Indian BMI cut-offs – Indian consensus review. (PMC)
The Takeaway
PCOS is manageable—and often dramatically so—when you combine(1) lifestyle, (2) guideline-based medication, and (3) regular monitoring. In the Indian context, adjusting for lower BMI cut-offs, low-GI traditional foods, and high cardiometabolic risk makes all the difference.
❌ALWAYS TAKE YOUR DOCTOR'S OR PHYSICIAN'S ADVICE BEFORE ANY LIFESTYLE CHANGES AND/OR MEDICATION.❌



Comments